Skip to main content
Caplight Logo









Rheon Medical

Rheon Medical

Private
LausanneHealthcare & Life Scienceshttps://rheonmedical.com/

Last Round

Series C

Dec 10, 2020

Total Funding Raised

$6.9M

Company Overview

Rheon Medical is a medical device company that develops and distributes adjustable glaucoma drainage devices for the surgical treatment of glaucoma.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

glaucoma drainage deviceadjustable glaucoma implantintraocular pressure controlophthalmology deviceglaucoma surgeryminimally invasive glaucoma surgeryMIGSfluidic control technologymedical device manufacturersurgical implantpost-operative managementeye surgery equipmenthypotony prevention

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rheon Medical Comparables

Compare Rheon Medical with similar companies based on industry and business-model similarity.

Rheon Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Myra Vision
84%
iSTAR Medical
83%
Sanoculis
83%

Rheon Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CDec 10, 2020
GrantSep 22, 2020
DebtJul 14, 2017
Series AOct 20, 2016

Key People

Founding team and executive leadership

Nikos Stergiopoulos

Founder and CEO

Founding Team

Constantinos Stergiopulos

Chief Technology Officer

Executive Team

Adan Villamarin

Chief Operating Officer

Executive Team

Rheon Medical Investors

Notable investors and investment history

Rheon Medical investors
InvestorRounds
EPFLSeries A
Foundation for Technological InnovationDebt
Lichtsteiner FoundationGrant
Blue Ocean VenturesSeries C, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 3, 2025

    Monthly visitors increased 41% MoM.

  • Jan 14, 2025

    Monthly visitors grew 153% MoM, reaching 2.4K.

Rheon Medical Filings

Explore SEC and related filing metadata, where available.

Rheon Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Rheon Medical's valuation, stock price, and market status.

Is Rheon Medical a public or private company?

Rheon Medical is a private company.

What is the current stock price of Rheon Medical?

Rheon Medical is a private company with no public stock price. No recent secondary market data is available.

How much is Rheon Medical worth (valuation)?

Valuation information for Rheon Medical is not publicly available.

Can I buy Rheon Medical stock?

Rheon Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Rheon Medical's last funding round?

Rheon Medical's most recent funding round was Series C on December 10, 2020.

Who are the main investors in Rheon Medical?

Key investors in Rheon Medical include Blue Ocean Ventures.

Will Rheon Medical IPO soon?

No public IPO plans have been announced for Rheon Medical.

How can I track Rheon Medical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rheon Medical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLausanne
Employee Range6
Year Founded2008
Last FundingDec 10, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?